Vasthera at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

Vasthera at BIO-Europe 2026 in Cologne: 1 session (1 talk).

OrganizationBIO-Europe 2026 Attendance
Vasthera
Seoul, South Korea
vasthera.com
Biotech
Clinical-stage company developing oral small molecules that restore redox signaling, led by a phase 1 therapy for pulmonary arterial hypertension.
Talk
Mon Nov 9
16:15–16:30
Cardiovascular, CNS: Vasthera Co., Ltd.
Oral drugs that rebalance the cell's oxidation signaling, led by one in a phase 1 trial for high blood pressure in the lung arteries.

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Vasthera

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction